Company intelligence / Profile preview

Avisol Capital Partners

New York, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Avisol Capital Partners is a specialized investment research and advisory firm focused exclusively on the healthcare and biotechnology sectors. The company provides in-depth clinical and financial analysis of biopharmaceutical companies, helping investors navigate complex clinical trial data and regulatory milestones. Their flagship service, the Total Pharma Tracker, offers real-time updates on FDA decisions, trial results, and market catalysts. Avisol's expertise lies in translating scientific developments into actionable investment insights for both institutional and retail clients.

Industry: Consulting

Beyond the preview

Go deeper on Avisol Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avisol Capital Partners.

Explore the full profile